1. A phase 1 study of eribulin mesylate (E7389), a novel microtubule‐targeting chemotherapeutic agent, in children with refractory or recurrent solid tumors: A Children's Oncology Group Phase 1 Consortium study (ADVL1314). Issue 8 (2nd May 2018) Authors: Schafer, Eric S.; Rau, Rachel E.; Berg, Stacey; Liu, Xiaowei; Minard, Charles G.; D'Adamo, David; Scott, Rachael; Reyderman, Larisa; Martinez, Gresel; Devarajan, Sandhya; Reid, Joel M.; Fox, Elizabeth; Weigel, Brenda J.; Blaney, Susan M. Journal: Pediatric blood & cancer Issue: Volume 65:Issue 8(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome‐Wide Association Study: Functional Epistatic Interaction Between SLC38A7 and ALPPL2. Issue 1 (18th March 2019) Authors: Dudenkov, Tanda M.; Liu, Duan; Cairns, Junmei; Devarajan, Sandhya; Zhuang, Yongxian; Ingle, James N.; Buzdar, Aman U.; Robson, Mark E.; Kubo, Michiaki; Batzler, Anthony; Barman, Poulami; Jenkins, Gregory D.; Carlson, Erin E.; Goetz, Matthew P.; Northfelt, Donald W.; Moreno‐Aspitia, Alvaro; Desta,... Journal: Clinical pharmacology & therapeutics Issue: Volume 106:Issue 1(2019) Page Start: 219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗